Dr Stefaan Bouchez, an anaesthesiologist from Ghent University Hospital in Belgium, discusses the haemodynamic effects of levosimendan and suggests it should be used as a first line of defence, rather than a last resort. Presented as part of the ‘ClinicalXChange’ sessions held on the Orion Pharma booth at the 37th ISICEM meeting, Brussels, 2017.
Dr Alexandre Mebazaa shares data from recent publications exploring the multiple effects of levosimendan.
Dr Alexandre Mebazaa discusses the inotropic and decongestive effects of levosimendan in heart failure and cardiogenic shock, in the light of recent studies.
Alternatively login via
Back to epgonline.org